Update: Adial Pharmaceuticals to Present at The 2019 Wall Street Conference
January 10 2019 - 10:24AM
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW),
www.adialpharma.com, a clinical-stage biopharmaceutical company
focused on the development of medicines for addiction, today
announced that William Stilley, President and Chief Executive
Officer of Adial, will be presenting at the 2019 Wall Street
Conference. The conference is by invitation only and will be held
on Wednesday, January 16th, 2019 at the Mar-a-Lago in Palm Beach,
Florida and the presentation will be at 1:20 PM Eastern Standard
Time.
The Wall Street Conference is one of the premiere conferences in
the venture capital arena and small cap marketplace. Financial
industry leaders from the hedge fund, investment banking, and
private equity worlds, as well as sophisticated investors, attend
the Wall Street Conference every year to discuss significant trends
in emerging and growth industries.
About Adial Pharmaceuticals, Inc.
Adial Pharmaceuticals is a clinical-stage
biopharmaceutical company focused on the development of treatments
for addictions. The Company’s lead investigational new drug
product, AD04, is a genetically targeted therapeutic agent for the
treatment of alcohol use disorder (“AUD”). A Phase 2b clinical
trial of AD04 for the treatment of AUD showed promising results in
reducing frequency of drinking, quantity of drinking and heavy
drinking (all with statistical significance), and no overt safety
concerns (there were no statistically significant serious adverse
events reported). The Company plans to commence a Phase 3 clinical
trial using AD04 for the potential treatment of AUD in subjects
with certain target genotypes, which are to be identified using the
Company’s proprietary companion diagnostic genetic test. AD04 is
also believed to have the potential to treat other addictive
disorders such as opioid use disorder, gambling, and obesity.
Contact:
Crescendo Communications, LLC David Waldman Tel: 212-671-1021
Email: dwaldman@crescendo-ir.com
Adial Pharmaceuticals (NASDAQ:ADIL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Adial Pharmaceuticals (NASDAQ:ADIL)
Historical Stock Chart
From Apr 2023 to Apr 2024